4//SEC Filing
Dimension Therapeutics, Inc. 4
Accession 0001209191-17-007660
CIK 0001592288operating
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:43 PM ET
Size
5.4 KB
Accession
0001209191-17-007660
Insider Transaction Report
Form 4
Wadsworth Samuel C.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-02-01+60,000→ 60,000 totalExercise: $1.90Exp: 2027-01-31→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]This stock option vests in forty-eight (48) equal monthly installments beginning on January 18, 2017.
Documents
Issuer
Dimension Therapeutics, Inc.
CIK 0001592288
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001592288
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 4:43 PM ET
- Size
- 5.4 KB